3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
8
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Neoplasms
4
Multiple Myeloma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Parasomnias
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
HIV Infections
2
Fatigue
2
Erectile Dysfunction
2
Carcinoma, Hepatocellular
2
Vitamin D Deficiency
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Untreated Advanced Non-small Cell Lung Cancer
1
Thrombocytopenia
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
OTHER_GOV
×
Hepatic Insufficiency
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled